Frontier intends to build the most modern cannabis cultivation facilities, working with infrastructure providers to create the most compliant and controlled environment possible to grow a high-grade pharmaceutical-grade crop.

The technology deployed will include advanced ‘Seed to Sale’ tracking and ‘hydroponic’ cultivation systems. By utilising the latest technologies and growing methods, Frontier will ensure that each harvest is of the highest quality and yield possible while maintaining a consistent and globally compliant replicable product.

Not only is this a requirement for international certification it allows the company to maintain 100% transparency. This provides recognition of the legitimacy of all cannabis operations.

  • Structure is a requirement for GMP/GAP certification & ensures 100% transparent growing process.
  • Authenticated growing from seed to sale tracking software automatically assists with logistical requirements.
  • €58 bn – Estimated European medical cannabis market value by 2028.
  • 95,000 – Medical cannabis prescriptions were made in Germany alone in 2018.

“Only once in a lifetime do you come across an investment opportunity that is good for people, the planet, and your portfolio; that is what we have in the cannabis industry”.

Alberto Liebenberg – Frontier Botanics